A Lesson for Apple Inc. (AAPL) from High School Biology

Page 1 of 2

Apple Inc. (NASDAQ:AAPL)‘s downward spiral that started in late September eroded billions of dollars from the market. The investors who remained loyal to the stock and didn’t sell out then are now left in utter disappointment. One such investor, the famous hedge fund manager and founder of Greenlight Capital David Einhorn, just couldn’t take it anymore. He’s recently came out and decided to sue the tech giant in an effort to push the company management to return some of the lost value back to shareholders using the billions of dollars hoarded in cash.

Einhorn proposes a preferred stock issuance plan. Contrarily, Mad Money’s Jim Cramer is proposing that Apple Inc. (NASDAQ:AAPL) should instead use that cash in crossing-over to other industries. He proposes buying companies like Twitter or Netflix. And then we have our fellow Fool blogger, Andres Cardenal, who proposes a share buyback for Apple. The possibilities are endless and shareholders should rest assured that, now that they’ve been sued, Apple management is seriously considering each potential route at the moment.

Apple Inc. (NASDAQ:AAPL)Nonetheless, the last few months have been very unnerving for shareholders as they watched the biggest company (by market capitalization) in the world decline to dirt cheap valuation multiples for no good reason. Many analysts have been speculating the possible reasons for the sudden unwarranted selling activity. Here’s my take on it.

Survival 101

Symbiosis, a biological term I learned in high school biology, explains the interaction between two different species in which both benefit (mutualism), one benefits and the other neither gets harmed nor benefits (commensalism), and one benefits and the other gets harmed (parasitism), as well as some other types. Interesting, sure, but why the biology lecture in a financial blog? Well, because I think there’s a lesson for Apple Inc. (NASDAQ:AAPL) to learn from it.

Technology Mutualism

In a space where almost every other competitor exists in symbiosis with one another, Apple Inc. (NASDAQ:AAPL) is left alone, all by itself to survive in this huge, perpetually growing, and fast-evolving technology industry. Look, for instance, at Nokia Corporation (ADR) (NYSE:NOK) which, at last, sensibly decided to give up its flopping Symbian OS to adopt its competitor’s OS–Windows 8. Stephen Elop finally gave in to the fact that his company needed rival Microsoft Corporation (NASDAQ:MSFT)’s assistance to survive. Together, the two benefit each other today. Nokia is finally selling ‘smartphones,’ not just phones, and Microsoft is starting to claw back some of its lost market share.

Out of the 6.6 million units Nokia sold in Q4, only 2.2 million were its Symbian phones. On the other hand, the Microsoft Windows 8 OS-based Lumia phones accounted for more than two thirds (4.4 million) of Nokia’s total units sold. The stock more than doubled following the news of Lumia phones’ sell-out. Likewise, Microsoft’s Windows OS’ fourth quarter market share also climbed to 2.6%, which is a 150% increase from the same quarter from the prior year. Both companies appear to be better positioned in this mutualistic relationship.

Similarly, the mighty Google Inc (NASDAQ:GOOG) gives away its Android OS to Samsung for free, letting it use its biggest applications ecosystem (second only to Apple Inc. (NASDAQ:AAPL)). In return, Google earns ad revenue from Samsung buyers, the biggest buyer-base of a mobile vendor in the world now.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!